State of Illinois
91st General Assembly
Legislation

   [ Search ]   [ Legislation ]
[ Home ]   [ Back ]   [ Bottom ]


[ Introduced ][ Engrossed ][ Senate Amendment 001 ]
[ Senate Amendment 002 ][ Senate Amendment 003 ]

91_HB1622enr

 
HB1622 Enrolled                                LRB9104751JSpc

 1        AN ACT concerning benefits for certain health treatments.

 2        WHEREAS, It is the intent  of  the  General  Assembly  to
 3    recognize that cancer clinical trials are designed to compare
 4    the  effectiveness  of  the standard medical treatment with a
 5    new  therapy  that  researchers  believe  will   prove   more
 6    effective,   based  on  scientific  evidence  and  that  such
 7    research provides the foundation for  improved  patient  care
 8    and decreased health care costs; and

 9        WHEREAS,  It  is  the  intent  of the General Assembly to
10    recognize that cancer clinical trials  involve  a  rigorously
11    developed  clinical  protocol  that includes goals, rationale
12    and background,  criteria  for  patient  selection,  specific
13    directions for administering therapy and monitoring patients,
14    definition of quantitative measures for determining treatment
15    response,  reporting  of results, and methods for documenting
16    and treating adverse reactions; and

17        WHEREAS, It is the intent  of  the  General  Assembly  to
18    recognize that virtually every major breakthrough for current
19    cancer  treatment  has  been  developed  through the clinical
20    trial system; and

21        WHEREAS, It is the intent  of  the  General  Assembly  to
22    acknowledge  that  cancer clinical trials can be cost neutral
23    in comparison to the standard therapy; therefore

24        Be it enacted by the People of  the  State  of  Illinois,
25    represented in the General Assembly:

26        Section  5.  The Civil Administrative Code of Illinois is
27    amended by adding Section 56.3 as follows:

28        (20 ILCS 1405/56.3 new)
29        Sec. 56.3.  Investigational cancer treatments; study.
 
HB1622 Enrolled            -2-                 LRB9104751JSpc
 1        (a)  The  Department  of  Insurance  shall   conduct   an
 2    analysis  and  study  of  costs and benefits derived from the
 3    implementation   of    the    coverage    requirements    for
 4    investigational  cancer  treatments established under Section
 5    356y of the Illinois Insurance Code. The  study  shall  cover
 6    the  years  2000, 2001, and 2002.  The study shall include an
 7    analysis of the effect of the coverage  requirements  on  the
 8    cost  of  insurance  and  health  care,  the  results  of the
 9    treatments to  patients,  the  mortality  rate  among  cancer
10    patients,  any  improvements  in  care  of  patients, and any
11    improvements in the quality of life of patients.
12        (b)  The Department shall report the results of its study
13    to the General Assembly and the Governor on or  before  March
14    1, 2003.

15        Section  10.  The  Illinois  Insurance Code is amended by
16    adding Section 356y as follows:

17        (215 ILCS 5/356y new)
18        Sec.   356y.  Coverage   for    investigational    cancer
19    treatments.
20        (a)  An  insurer that issues, delivers, amends, or renews
21    an  individual  or  group  policy  of  accident  and   health
22    insurance  in  this  State  more  than  120  days  after  the
23    effective  date  of  this  amendatory Act of the 91st General
24    Assembly must offer to the applicant or policyholder coverage
25    for  routine  patient  care  of  insureds,   when   medically
26    appropriate  and the insured has a terminal condition related
27    to cancer that according to the  diagnosis  of  the  treating
28    physician, licensed to practice medicine in all its branches,
29    is considered life threatening, to participate in an approved
30    cancer  research  trial  and  shall  provide coverage for the
31    patient care  provided  pursuant  to  investigational  cancer
32    treatments  as  provided  in  subsection (b).  Coverage under
 
HB1622 Enrolled            -3-                 LRB9104751JSpc
 1    this Section may have an annual benefit limit of $10,000.
 2        (b)  Coverage shall include routine  patient  care  costs
 3    such  as  blood tests, x-rays, bone scans, magnetic resonance
 4    images, patient visits,  hospital  stays,  or  other  similar
 5    costs  generally  incurred  by  the insured party in standard
 6    cancer treatment. Routine  patient  care  costs  specifically
 7    shall  not  include the cost of any clinical trial therapies,
 8    regimens,   or   combinations   thereof,   any    drugs    or
 9    pharmaceuticals  in  connection  with  an  approved  clinical
10    trial,  any costs associated with the provision of any goods,
11    services, or benefits that are  generally  furnished  without
12    charge  in connection with an approved clinical trial program
13    for treatment of cancer, any additional costs associated with
14    the provision  of  any  goods,  services,  or  benefits  that
15    previously have been provided to, paid for, or reimbursed, or
16    any  other  similar  costs.  Routine patient care costs shall
17    specifically not include costs  for  treatments  or  services
18    prescribed  for  the convenience of the insured, enrollee, or
19    physician.  It is specifically the intent of this Section not
20    to relieve  the  sponsor  or  a  clinical  trial  program  of
21    financial responsibility for accepted costs of the program.
22        (c)  For  purposes  of this Section, coverage is provided
23    only for cancer  trials  that  meet  each  of  the  following
24    criteria:
25             (1)  the effectiveness of the treatment has not been
26        determined relative to established therapies;
27             (2)  the  trial  is  under clinical investigation as
28        part of an approved cancer research trial  in  Phase  II,
29        Phase III, or Phase IV of investigation;
30             (3)  the  trial is approved by the U.S. Secretary of
31        Health and Human Services, the Director of  the  National
32        Institutes  of  Health,  the Commissioner of the Food and
33        Drug Administration (through an investigational new  drug
34        exemption under Section 505(l) of the federal Food, Drug,
 
HB1622 Enrolled            -4-                 LRB9104751JSpc
 1        and  Cosmetic  Act or an investigational device exemption
 2        under  Section  520(g)  of  that  Act),  or  a  qualified
 3        nongovernmental cancer  research  entity  as  defined  in
 4        guidelines of the National Institutes of Health or a peer
 5        reviewed and approved cancer research program, as defined
 6        by  the  U.S.  Secretary  of  Health  and Human Services,
 7        conducted for the primary purpose of determining  whether
 8        or  not  a cancer treatment is safe or efficacious or has
 9        any other characteristic of a cancer treatment that  must
10        be  demonstrated  in order for the cancer treatment to be
11        medically necessary or appropriate;
12             (4)  the trial is being conducted at multiple  sites
13        throughout the State;
14             (5)  the  patient's  primary care physician, if any,
15        is involved in the coordination of care; and
16             (6)  the results of the investigational  trial  will
17        be  submitted for publication in peer-reviewed scientific
18        studies, research, or literature published in or accepted
19        for publication by medical journals that meet  nationally
20        recognized  requirements  for  scientific manuscripts and
21        that submit most of their published articles  for  review
22        by  experts  who  are  not  part  of the editorial staff.
23        These studies may include those conducted by or under the
24        auspices of the federal government's  Agency  for  Health
25        Care  Policy and Research, National Institutes of Health,
26        National Cancer Institute, National Academy of  Sciences,
27        Health  Care  Financing  Administration, and any national
28        board recognized by the National Institutes of Health for
29        the purpose of evaluating the  medical  value  of  health
30        services.
31        (d)  This Section is repealed on January 1, 2003.

32        Section  15.  The  Health Maintenance Organization Act is
33    amended by changing Section 5-3 as follows:
 
HB1622 Enrolled            -5-                 LRB9104751JSpc
 1        (215 ILCS 125/5-3) (from Ch. 111 1/2, par. 1411.2)
 2        Sec. 5-3.  Insurance Code provisions.
 3        (a)  Health Maintenance Organizations shall be subject to
 4    the provisions of Sections 133, 134, 137, 140, 141.1,  141.2,
 5    141.3,  143,  143c, 147, 148, 149, 151, 152, 153, 154, 154.5,
 6    154.6, 154.7, 154.8, 155.04, 355.2, 356m, 356v,  356w,  356x,
 7    356y, 367i, 401, 401.1, 402, 403, 403A, 408, 408.2, 409, 412,
 8    444,  and  444.1,  paragraph (c) of subsection (2) of Section
 9    367, and Articles VIII 1/2, XII, XII  1/2,  XIII,  XIII  1/2,
10    XXV, and XXVI of the Illinois Insurance Code.
11        (b)  For  purposes of the Illinois Insurance Code, except
12    for Sections 444 and 444.1 and Articles XIII  and  XIII  1/2,
13    Health  Maintenance Organizations in the following categories
14    are deemed to be "domestic companies":
15             (1)  a  corporation  authorized  under  the   Dental
16        Service  Plan  Act or the Voluntary Health Services Plans
17        Act;
18             (2)  a corporation organized under the laws of  this
19        State; or
20             (3)  a  corporation  organized  under  the  laws  of
21        another  state, 30% or more of the enrollees of which are
22        residents of this State, except a corporation subject  to
23        substantially  the  same  requirements  in  its  state of
24        organization as is a  "domestic  company"  under  Article
25        VIII 1/2 of the Illinois Insurance Code.
26        (c)  In  considering  the merger, consolidation, or other
27    acquisition of control of a Health  Maintenance  Organization
28    pursuant to Article VIII 1/2 of the Illinois Insurance Code,
29             (1)  the  Director  shall give primary consideration
30        to the continuation of  benefits  to  enrollees  and  the
31        financial  conditions  of the acquired Health Maintenance
32        Organization after the merger,  consolidation,  or  other
33        acquisition of control takes effect;
34             (2)(i)  the  criteria specified in subsection (1)(b)
 
HB1622 Enrolled            -6-                 LRB9104751JSpc
 1        of Section 131.8 of the Illinois Insurance Code shall not
 2        apply and (ii) the Director, in making his  determination
 3        with  respect  to  the  merger,  consolidation,  or other
 4        acquisition of control, need not take  into  account  the
 5        effect  on  competition  of the merger, consolidation, or
 6        other acquisition of control;
 7             (3)  the Director shall have the  power  to  require
 8        the following information:
 9                  (A)  certification by an independent actuary of
10             the   adequacy   of   the  reserves  of  the  Health
11             Maintenance Organization sought to be acquired;
12                  (B)  pro forma financial statements  reflecting
13             the combined balance sheets of the acquiring company
14             and the Health Maintenance Organization sought to be
15             acquired  as of the end of the preceding year and as
16             of a date 90 days prior to the acquisition, as  well
17             as   pro   forma   financial  statements  reflecting
18             projected combined  operation  for  a  period  of  2
19             years;
20                  (C)  a  pro  forma  business  plan detailing an
21             acquiring  party's  plans  with   respect   to   the
22             operation  of  the  Health  Maintenance Organization
23             sought to be acquired for a period of not less  than
24             3 years; and
25                  (D)  such  other  information  as  the Director
26             shall require.
27        (d)  The provisions of Article VIII 1/2 of  the  Illinois
28    Insurance  Code  and this Section 5-3 shall apply to the sale
29    by any health maintenance organization of greater than 10% of
30    its enrollee population  (including  without  limitation  the
31    health  maintenance organization's right, title, and interest
32    in and to its health care certificates).
33        (e)  In considering any management  contract  or  service
34    agreement  subject to Section 141.1 of the Illinois Insurance
 
HB1622 Enrolled            -7-                 LRB9104751JSpc
 1    Code, the Director (i) shall, in  addition  to  the  criteria
 2    specified  in  Section  141.2 of the Illinois Insurance Code,
 3    take into account the effect of the  management  contract  or
 4    service   agreement   on  the  continuation  of  benefits  to
 5    enrollees  and  the  financial  condition   of   the   health
 6    maintenance  organization to be managed or serviced, and (ii)
 7    need not take into  account  the  effect  of  the  management
 8    contract or service agreement on competition.
 9        (f)  Except  for  small employer groups as defined in the
10    Small Employer Rating, Renewability  and  Portability  Health
11    Insurance  Act and except for medicare supplement policies as
12    defined in Section 363 of  the  Illinois  Insurance  Code,  a
13    Health  Maintenance Organization may by contract agree with a
14    group or other enrollment unit to effect  refunds  or  charge
15    additional premiums under the following terms and conditions:
16             (i)  the  amount  of, and other terms and conditions
17        with respect to, the refund or additional premium are set
18        forth in the group or enrollment unit contract agreed  in
19        advance of the period for which a refund is to be paid or
20        additional  premium  is to be charged (which period shall
21        not be less than one year); and
22             (ii)  the amount of the refund or additional premium
23        shall  not  exceed  20%   of   the   Health   Maintenance
24        Organization's profitable or unprofitable experience with
25        respect  to  the  group  or other enrollment unit for the
26        period (and, for  purposes  of  a  refund  or  additional
27        premium,  the profitable or unprofitable experience shall
28        be calculated taking into account a pro rata share of the
29        Health  Maintenance  Organization's  administrative   and
30        marketing  expenses,  but shall not include any refund to
31        be made or additional premium to be paid pursuant to this
32        subsection (f)).  The Health Maintenance Organization and
33        the  group  or  enrollment  unit  may  agree   that   the
34        profitable  or  unprofitable experience may be calculated
 
HB1622 Enrolled            -8-                 LRB9104751JSpc
 1        taking into account the refund period and the immediately
 2        preceding 2 plan years.
 3        The  Health  Maintenance  Organization  shall  include  a
 4    statement in the evidence of coverage issued to each enrollee
 5    describing the possibility of a refund or additional premium,
 6    and upon request of any group or enrollment unit, provide  to
 7    the group or enrollment unit a description of the method used
 8    to   calculate  (1)  the  Health  Maintenance  Organization's
 9    profitable experience with respect to the group or enrollment
10    unit and the resulting refund to the group or enrollment unit
11    or (2) the  Health  Maintenance  Organization's  unprofitable
12    experience  with  respect to the group or enrollment unit and
13    the resulting additional premium to be paid by the  group  or
14    enrollment unit.
15        In   no  event  shall  the  Illinois  Health  Maintenance
16    Organization  Guaranty  Association  be  liable  to  pay  any
17    contractual obligation of an insolvent  organization  to  pay
18    any refund authorized under this Section.
19    (Source: P.A.   89-90,  eff.  6-30-95;  90-25,  eff.  1-1-98;
20    90-177, eff.  7-23-97;  90-372,  eff.  7-1-98;  90-583,  eff.
21    5-29-98;  90-655,  eff. 7-30-98; 90-741, eff. 1-1-99; revised
22    9-8-98.)

23        Section 20.  The Voluntary Health Services Plans  Act  is
24    amended by changing Section 10 as follows:

25        (215 ILCS 165/10) (from Ch. 32, par. 604)
26        Sec.   10.  Application  of  Insurance  Code  provisions.
27    Health services plan corporations and all persons  interested
28    therein   or  dealing  therewith  shall  be  subject  to  the
29    provisions of Article XII 1/2 and  Sections  3.1,  133,  140,
30    143,  143c,  149,  354,  355.2, 356r, 356t, 356u, 356v, 356w,
31    356x, 356y, 367.2, 401, 401.1, 402, 403,  403A,  408,  408.2,
32    and  412,  and  paragraphs (7) and (15) of Section 367 of the
 
HB1622 Enrolled            -9-                 LRB9104751JSpc
 1    Illinois Insurance Code.
 2    (Source: P.A.  89-514,  eff.  7-17-96;  90-7,  eff.  6-10-97;
 3    90-25,  eff.  1-1-98;  90-655,  eff.  7-30-98;  90-741,  eff.
 4    1-1-99.)

 5        Section 99.  Effective date.  This Act  takes  effect  on
 6    January 1, 2000.

[ Top ]